top of page
Search

Autoimmune Disorder Drug Delivery Devices Market Growth Insight – MarkNtel Report Expected 16.89% CAGR Growth Through 2027

  • Writer: Amit Kumar
    Amit Kumar
  • Jan 31, 2024
  • 3 min read


MarkNtel Advisors who is leading market research company, has recently published a research report, titled Global “Autoimmune Disorder Drug Delivery Devices Market”. The report is estimated historical data, base year and forecast period and the projections are made for the next five years, i.e., 2022-27. The data, facts, and figures are sourced from reliable platforms, including government portals, white papers, and others.


Important Notes: In case you missed it, we are currently revising our reports. Click on the "request Sample report" button to get the most latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.


Market Study Period

Historical Data: 2017-20

Base Year: 2021

Forecast Period: 2022-27

CAGR (2022-2027): 16.89%


Global Autoimmune Disorder Drug Delivery Devices Market Insights:

The Global Autoimmune Disorder Drug Delivery Devices Market is projected to grow at a CAGR of around 16.89% in terms of revenue during the forecast period, i.e., 2022-27. The report covers each and every aspect of the market in detail, offering actionable insights to the stakeholders. We extensively cover key trends, opportunities, possible challenges, and major growth drivers for the industry. The report also highlights the role and involvement of governments and other relevant factors that promote market growth.


Global Autoimmune Disorder Drug Delivery Devices Market Growth Drivers:

Rising Geriatric Population - The selection of T-cells with increased affinity to self-antigens, and latent viruses, which result in the aging of the immune system, are the major factors contributing to an increase in autoimmune disorders in the elderly age population globally. According to the World Health Organization (WHO), the number of people aged over 60 is expected to nearly double from 12% to 22% by 2050.

Furthermore, globally, the aging population & increased immune disorders such as Alzheimer's Disease, Rheumatoid Arthritis, diabetes, etc., combined with the decrease in gastric pH, which limits drug absorption, are leading to an increase in demand for autoimmune disorder drug delivery devices.


Explore the Complete Autoimmune Disorder Drug Delivery Devices Market Analysis Report - https://www.marknteladvisors.com/research-library/global-autoimmune-disorder-drug-delivery-devices-market.html


Which segments are covered in the Autoimmune Disorder Drug Delivery Devices Market Research Report?

  • By Product Type

  • Prefilled Syringes

  • Auto-injectors

  • Infusion pumps

  • Nebulizers

  • Nasal sprays

  • Others (Eyedropper, Transdermal patches, etc.)

  • By Indication

  • Psoriasis

  • Rheumatoid Arthritis

  • Multiple Sclerosis

  • Inflammatory Bowel Diseases

  • Systemic Lupus Erythematosus

  • Diabetes Mellitus

  • Others (Guillain Barre Syndrome, Grave’s Disease, etc.)

  • By Manufacturing Type   

  • In-House Manufacturing

  • Outsourced Manufacturing

  • By End User

  • Hospitals

  • Diagnostic centres

  • Ambulatory surgery centres

  • Others (Clinics, Home care settings, etc.)

  • By Region

  • North America

  • South America

  • Europe

  • Middle East & Africa

  • Asia-Pacific


Top 10 Key Brands/Players in the Autoimmune Disorder Drug Delivery Devices Market

Our analysts have closely analyzed leading players within the industry, providing stakeholders with valuable insights into the competitive landscape. This enables them to formulate strategic tactics based on the comprehensive data compiled in the report. The information encompasses recent developments, mergers and acquisitions, product/service launches, expansion plans, and revenue-generating opportunities. Notable entities featured in the report include:

  • Amgen Inc.

  • AbbVie Inc.

  • Bayer AG

  • Biogen Inc.

  • Eli Lilly and Company

  • Bristol-Myers Squibb Company

  • Hoffmann-La Roche AG

  • GlaxoSmithKline plc

  • Johnson & Johnson Services, Inc.

  • The Merck Group

  • Novartis International AG

  • Sanofi S.A.

  • Teva Pharmaceutical Industries Ltd.

  • UCB Pharma SA.



Frequently Asked Questions

  1. Which companies dominate the Autoimmune Disorder Drug Delivery Devices Market in terms of market share?

  2. What is the projected market size of Autoimmune Disorder Drug Delivery Devices Market in 2027?

  3. What key factor is anticipated to propel the Autoimmune Disorder Drug Delivery Devices Market by 2027?

  4. How big is the Autoimmune Disorder Drug Delivery Devices Market?


Other Reports –

About us:

Confronting a market challenge? MarkNtel is here to support you. We specialize in in-depth analysis across 15 dynamic industries, providing customized research, consulting, and data solutions to meet your specific requirements. Whether it's launching a product or gaining a competitive edge, we facilitate well-informed decisions that pave the way for enduring success.

Empowering your financial future is our commitment at MarkNtel. Serving as your trusted research partner, we navigate intricate markets, pinpoint high-potential opportunities, and formulate early-stage strategies for superior returns. Allow us to illuminate your path to financial prosperity.


Contact us:

Should you have any inquiries, our team of seasoned experts is available to help. You can contact us via phone, email, or by filling out our online contact form. Be assured that we will exert every effort to promptly attend to your query and furnish the necessary information.


Media Representative

Phone: +1 628 895 8081

 
 
 

Comments

bottom of page